Adam Gridley

Adam Gridley is the interim President and CEO at Theirtogenics. Prior to this, they served as the Chief Executive Officer at Entera Bio Ltd. from August 2019 to August 2020. Adam also served on the Board of Directors for the Alliance for Regenerative Medicine from January 2019 to September 2019. Gridley has also held positions at LifeSprout, Theirtogenics Corporation, and Merz North America. At Merz North America, they served as Senior Vice President, Technical Operations and was responsible for global manufacturing, distribution, information technology, quality operations, facilities, sourcing, and customer service. Adam was also an executive officer and member of North American and Global Leadership Teams.

Adam Gridley has a MBA from the University of Denver - Daniels College of Business and a BS in Accounting from the University of Denver.

and Jon Lieber - Interim Chief Financial Officer reports to Adam Gridley.